Profile image
Story Views

Last Hour:
Last 24 Hours:

Gastrointestinal Therapeutics Market To Grow At A CAGR Of 6.5% During The Period 2016-2020

Friday, October 14, 2016 3:07
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Gastrointestinal disorders include both functional and motility disorders affecting the gastrointestinal tract. Functional disorders involve an abnormality in the working of the gastrointestinal tract. They are the most common type of disorders and present with disturbances in motility, visceral hypersensitivity, changes in the mucosal and immune function, variations in central nervous system processing, and altered gut microbiota. Motility disorders are characterized by changes in the movement of the gastrointestinal tract and the transfer of its contents. Some of the most common gastrointestinal functional and motility disorders include IBS, GERD, Crohn’s disease, ulcerative colitis, and peptic ulcers.

Publisher’s analysts forecast the global gastrointestinal therapeutics market to grow at a CAGR of 6.5% during the period 2016-2020.

For more information about this report:             

Covered in this report 
The report covers the present scenario and the growth prospects of the global gastrointestinal therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of various gastrointestinal disorders including IBD, and irritable bowel syndrome (IBS).

The market is divided into the following segments based on geography: 

Publisher’s report, Global Gastrointestinal Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
-Johnson & Johnson


Request Sample Copy at     


Other prominent vendors 
-Ajinomoto Pharmaceuticals
-Alfa Wassermann
-Arena Pharmaceuticals
-Astellas Pharma
-Avaxia Biologics
-Biogen Idec
-Cosmo Pharmaceuticals
-Drais Pharmaceuticals
-Eli Lilly
-Enlivex Therapeutics
-F. Hoffmann-La Roche
-Ferring Pharmaceuticals
-FF Pharma
-Gilead Sciences
-Hutchison Medi Pharma
-Immune Pharmaceuticals
-InDex Pharmaceuticals
-Ironwood Pharmaceuticals
-Kaken Pharmaceutical
-Kang Stem Biotech
-Kissei Pharmaceutical
-Kyowa Hakko Kirin
-Lexicon Pharmaceuticals
-Lipid Therapeutics
-Mitsubishi Tanabe
-Mochida Pharmaceutical
-Ono Pharmaceutical
-Procter & Gamble
-Qu Biologics
-RedHill Biopharma
-Salix Pharmaceuticals
-Shield Therapeutics
-Sterna Biologicals
-Synergy Pharmaceuticals
-Synthetic Biologics
-Tillotts Pharma
-TSD Japan
-Zeria Pharmaceutical

Inquire for Report at    

Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.